Mutual of America Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,483
| Closed | -$198K | – | 1555 |
|
|
2022
Q3 | $198K | Buy |
7,483
+1,108
| +17% | +$29.3K | ﹤0.01% | 1366 |
|
|
2022
Q2 | $157K | Buy |
6,375
+952
| +18% | +$23.4K | ﹤0.01% | 1397 |
|
|
2022
Q1 | $180K | Buy |
5,423
+281
| +5% | +$9.33K | ﹤0.01% | 1379 |
|
|
2021
Q4 | $168K | Buy |
5,142
+143
| +3% | +$4.67K | ﹤0.01% | 1399 |
|
|
2021
Q3 | $210K | Buy |
4,999
+43
| +0.9% | +$1.81K | ﹤0.01% | 1338 |
|
|
2021
Q2 | $193K | Buy |
4,956
+302
| +6% | +$11.8K | ﹤0.01% | 1400 |
|
|
2021
Q1 | $159K | Buy |
4,654
+897
| +24% | +$30.6K | ﹤0.01% | 1427 |
|
|
2020
Q4 | $170K | Buy |
3,757
+163
| +5% | +$7.38K | ﹤0.01% | 1335 |
|
|
2020
Q3 | $99K | Buy |
3,594
+2,044
| +132% | +$56.3K | ﹤0.01% | 1403 |
|
|
2020
Q2 | $57K | Buy |
1,550
+179
| +13% | +$6.58K | ﹤0.01% | 1307 |
|
|
2020
Q1 | $44K | Buy |
1,371
+294
| +27% | +$9.44K | ﹤0.01% | 1317 |
|
|
2019
Q4 | $44K | Sell |
1,077
-77
| -7% | -$3.15K | ﹤0.01% | 1383 |
|
|
2019
Q3 | $41K | Buy |
1,154
+42
| +4% | +$1.49K | ﹤0.01% | 1389 |
|
|
2019
Q2 | $57K | Buy |
1,112
+231
| +26% | +$11.8K | ﹤0.01% | 1306 |
|
|
2019
Q1 | $50K | Buy |
881
+147
| +20% | +$8.34K | ﹤0.01% | 1284 |
|
|
2018
Q4 | $31K | Buy |
734
+175
| +31% | +$7.39K | ﹤0.01% | 1360 |
|
|
2018
Q3 | $42K | Buy |
559
+460
| +465% | +$34.6K | ﹤0.01% | 1282 |
|
|
2018
Q2 | $7K | Buy |
+99
| New | +$7K | ﹤0.01% | 1312 |
|